# From Beijing to 40+ Countries: AK Medical's Journey in Numbers

> Key milestones of AK Medical Holdings (HKEX: 01789.HK) — from its 2003 founding to China's first approved 3D-printed implant, the JRI Orthopaedics acquisition, and 1.2 million implants worldwide.

- URL: https://www.ak-medical-global.com/blog/ak-medical-2026-milestones
- Published: 2026-03-10
- Author: AK Medical Editorial Team, AK Medical Holdings Limited
- Topics: Company, Investor Relations, Milestones

AK Medical Holdings Limited began in 2003 as a Beijing orthopedic implant manufacturer. Two decades later it is a pioneer of 3D-printed orthopedic implants — its 3D-printed hip cup was the first 3D-printed orthopedic implant approved in China, in 2015 [1] — listed on the Hong Kong Stock Exchange, and trusted by more than 7,500 hospitals. Here is the journey in numbers.

## Timeline of key milestones

| Year | Milestone |
| --- | --- |
| 2003 | Founded in Beijing, Changping Science Park |
| 2015 | NMPA (CFDA) approves China's first 3D-printed orthopedic implant — AK Medical's acetabular cup |
| 2017 | IPO on the Main Board of the Hong Kong Stock Exchange (stock code **01789.HK**) |
| 2018 | Acquisition of JRI Orthopaedics Ltd. (Sheffield, UK), adding Supravit™ coating technology and 50+ years of clinical heritage |
| 2020 | Acquisition of Beijing Libeier, expanding into spine and trauma implants |
| Today | 1.2M+ implants delivered, 7,500+ partner hospitals, 40+ countries, 600+ patents |

## The technology portfolio behind the growth

- **3DACT™** — proprietary 3D printing precision building technology; 210+ patents
- **Supravit™** — vacuum plasma spray hydroxyapatite coating (JRI Orthopaedics, Queen's Award for Technology)
- **One Point™** — surgical navigation and robotic assistance platform
- **ICOS™** — end-to-end custom implant pathway, ~1,000 complex cases completed

## Regulatory footprint

AK Medical products carry approvals across major markets:

- **NMPA Class III** registrations in China (70+, the country's highest device tier)
- **CE Mark** for the EU/EEA
- **FDA 510(k)** clearances for the United States

## Group structure

The group today spans four operating companies:

1. **Beijing AKEC Medical** — flagship manufacturing and R&D, Beijing
2. **ITI Medical (Changzhou)** — instrument and implant production
3. **JRI Orthopaedics** — UK-based R&D, manufacturing and Supravit™ coatings
4. **Beijing Libeier** — spine and trauma implant specialist

For investor materials, corporate governance information and HKEX filings, see the [Investor Relations section](/#investors), or [contact us](/#contact) directly.

## References

1. 健康时报 (Health Times, People's Daily), 12 October 2015 — report on the registration of the 3D-printed artificial hip developed by Peking University Third Hospital and Beijing AKEC Medical. [paper.people.com.cn](https://paper.people.com.cn/jksb/html/2015-10/12/content_1625316.htm)
2. South China Morning Post, 2015 — "'Just the beginning': China approves world's first 3D-printed hip". [scmp.com](https://scmp.com/tech/science-research/article/1854369/just-beginning-china-approves-worlds-first-3d-printed-hip)